Auteur M. VENTURA VILAMALA

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Nouveauté

Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project

T. M. BRUNT ; C. NAGY ; A. BUCHELI ; D. MARTINS ; M. UGARTE ; C. BÉDUWÉ ; M. VENTURA VILAMALA | 2017
Dans Drug Testing and Analysis (Vol.9, n°1-2, January-February 2017) Article : Périodique

Drug testing is a harm reduction strategy that has been adopted by certain countries in Europe. Drug users are able to hand in their drugs voluntarily for chemical analysis of composition and dose. Drug users will be alerted about dangerous test[...]

Plus d'info

Ajouter à la sélection

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

C. VIDAL-GINÉ ; I. FORNIS ESPINOSA ; M. VENTURA VILAMALA | 2014
Dans Drug Testing and Analysis (Vol.6, n°7-8, July-August 2014) Article : Périodique

The use of new psychoactive substances (NPS) as adulterants has received little attention in the literature. In this paper, results from Energy Control's drug checking service documenting the use of NPS as adulterants of controlled drugs are pre[...]

Plus d'info

Ajouter à la sélection

The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal's Boom Festival

D. MARTINS ; M. J. BARRATT ; C. V. PIRES ; H. CARVALHO ; M. VENTURA VILAMALA ; I. FORNIS ESPINOSA ; H. VALENTE | 2017
Dans Human Psychopharmacology: Clinical and Experimental (Vol.32, n°3, May 2017) Article : Périodique

Objective: This paper describes the misrepresentation of LSD at Portugal's Boom Festival 2014 and the prevention of unintentional consumption of DOx and 25x-NBOMe among LSD consumers attending a drug-checking service. Methods: Two hundred forty[...]

Plus d'info

Ajouter à la sélection